Quarterly report pursuant to Section 13 or 15(d)

Acquisitions, Investments, and Licenses (Details 3)

v2.4.0.8
Acquisitions, Investments, and Licenses (Details 3) (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2013
Dec. 31, 2012
Jun. 30, 2012
Dec. 31, 2011
Current assets:        
Cash and cash equivalents $ 119,061 [1] $ 27,361 [1] $ 38,171 $ 71,516
Accounts receivable, net 22,227 [1] 21,162 [1]    
Inventory, net 19,778 [1] 22,261 [1]    
Prepaid expenses and other current assets 19,023 [1] 7,873 [1]    
Total current assets 230,116 [1] 78,657 [1]    
Property, plant and equipment, net 16,577 [1] 16,526 [1]    
Intangible assets, net 79,775 [1] 84,238 [1]    
Goodwill 82,086 [1] 80,450 [1]    
Other assets 2,784 [1] 2,777 [1]    
Total assets 641,080 [1] 289,830 [1]    
Current liabilities:        
Accounts payable 11,646 [1] 10,200 [1]    
Accrued expenses 31,045 [1] 24,656 [1]    
Total current liabilities 59,469 [1] 52,382 [1]    
Other long-term liabilities 80,603 [1] 34,168 [1]    
Total liabilities 328,596 [1] 86,550 [1]    
SciVac [Member]
        
Current assets:        
Cash and cash equivalents 363 174    
Accounts receivable, net 266 387    
Inventory, net 1,573 1,092    
Prepaid expenses and other current assets 132 199    
Total current assets 2,334 1,852    
Property, plant and equipment, net 1,425 1,539    
Intangible assets, net 1,128 1,154    
Goodwill 822 796    
Other assets 298 231    
Total assets 6,007 5,572    
Current liabilities:        
Accounts payable 1,254 1,108    
Accrued expenses 5,157 2,859    
Notes payable 1,132 0    
Total current liabilities 7,543 3,967    
Other long-term liabilities 282 1,529    
Total liabilities $ 7,825 $ 5,496    
[1] As of June 30, 2013 and December 31, 2012, total assets include $6.0 million and $5.6 million, respectively, and total liabilities include $7.8 million and $5.5 million, respectively related to SciVac Ltd ("SciVac"), previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities are those as to which there is no recourse against us. Refer to Note 5.